Adverse Events During Supervised Exercise Interventions in Pediatric Oncology-A Nationwide Survey

Gauß G, Beller R, Boos J, Däggelmann J, Stalf H, Wiskemann J, Götte M (2021)

In: Frontiers in pediatrics, 9.

Forschungsartikel (Zeitschrift)

Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data

Würthwein G, Lanvers-Kaminsky C, Siebel C, Gerß J, Möricke A, Zimmermann M, Stary J, Smisek P, Schrappe M, Rizzari C, Zucchetti M, Hempel G, Wicha SG, Boos J (2021)

In: European Journal of Drug Metabolism and Pharmacokinetics, 46(2).

Forschungsartikel (Zeitschrift)

Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure

Siebel C, Würthwein G, Lanvers-Kaminsky C, André N, Berthold F, Castelli I, Chastagner P, Doz F, English M, Escherich G, Frühwald MC, Graf N, Groll AH, Ruggiero A, Hempel G, Boos J (2020)

In: BMC pharmacology & toxicology, 21(1).

Forschungsartikel (Zeitschrift)

Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study

Würthwein G, Lanvers-Kaminsky C, Gerss J, Möricke A, Zimmermann M, Stary J, Smisek P, Attarbaschi A, Nath C, Zucchetti M, Rizzari C, Schrappe M, Boos J (2020)

In: Therapeutic Drug Monitoring, 42(3).

Forschungsartikel (Zeitschrift)

Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia

Khalil A, Würthwein G, Golitsch J, Hempel G, Fobker M, Gerss J, Möricke A, Zimmermann M, Smisek P, Zucchetti M, Nath C, Attarbaschi A, Stackelberg A, Gökbuget N, Rizzari C, Conter V, Schrappe M, Boos J, Lanvers-Kaminsky C (2020)

In: Haematologica, Online ahead of print.

Forschungsartikel (Zeitschrift)

Publikationen

Kontakt

Top-Links

Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach Siebel C, Lanvers-Kaminsky C, Alten J, Smisek P, Nath CE, Rizzari C, Boos J, Würthwein G (2021) In: European Journal of Drug Metabolism and Pharmacokinetics, 2021. Forschungsartikel (Zeitschrift)
Adverse Events During Supervised Exercise Interventions in Pediatric Oncology-A Nationwide Survey Gauß G, Beller R, Boos J, Däggelmann J, Stalf H, Wiskemann J, Götte M (2021) In: Frontiers in pediatrics, 9. Forschungsartikel (Zeitschrift)
Physical Activity, Exercise and Sports in Young Cancer Patients Götte M, Kesting S, Boos J (2021) In: Beck JD, Bokemeyer C, Langer T (Hrsg.), Late Treatment Effects and Cancer Survivor Care in the Young. . Forschungsartikel (Buchbeitrag)
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data Würthwein G, Lanvers-Kaminsky C, Siebel C, Gerß J, Möricke A, Zimmermann M, Stary J, Smisek P, Schrappe M, Rizzari C, Zucchetti M, Hempel G, Wicha SG, Boos J (2021) In: European Journal of Drug Metabolism and Pharmacokinetics, 46(2). Forschungsartikel (Zeitschrift)
Asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly-diagnosed acute lymphoblastic leukemia Lanvers-Kaminsky C, Niemann A, Eveslage M, Beck J, Köhnke T, Martin S, Wit M, Spriewald B, Hauspurg H, Hoelzer D, Boos J, Gökbuget N (2020) In: Leukemia & lymphoma, 61(1). Forschungsartikel (Zeitschrift)
Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure Siebel C, Würthwein G, Lanvers-Kaminsky C, André N, Berthold F, Castelli I, Chastagner P, Doz F, English M, Escherich G, Frühwald MC, Graf N, Groll AH, Ruggiero A, Hempel G, Boos J (2020) In: BMC pharmacology & toxicology, 21(1). Forschungsartikel (Zeitschrift)
Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR Berthold F, Faldum A, Ernst A, Boos J, Dilloo D, Eggert A, Fischer M, Frühwald M, Henze G, Klingebiel T, Kratz C, Kremens B, Krug B, Leuschner I, Schmidt M, Schmidt R, Schumacher-Kuckelkorn R, von Schweinitz D, Schilling FH, Theissen J, Volland R, Hero B, Simon T (2020) In: Annals of Oncology, 31(3). Forschungsartikel (Zeitschrift)
Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study Würthwein G, Lanvers-Kaminsky C, Gerss J, Möricke A, Zimmermann M, Stary J, Smisek P, Attarbaschi A, Nath C, Zucchetti M, Rizzari C, Schrappe M, Boos J (2020) In: Therapeutic Drug Monitoring, 42(3). Forschungsartikel (Zeitschrift)
Bioanalysis of doxorubicin aglycone metabolites in human plasma samples-implications for doxorubicin drug monitoring Siebel C, Lanvers-Kaminsky C, Würthwein G, Hempel G, Boos J (2020) In: Scientific Reports, 10(1). Forschungsartikel (Zeitschrift)
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia Khalil A, Würthwein G, Golitsch J, Hempel G, Fobker M, Gerss J, Möricke A, Zimmermann M, Smisek P, Zucchetti M, Nath C, Attarbaschi A, Stackelberg A, Gökbuget N, Rizzari C, Conter V, Schrappe M, Boos J, Lanvers-Kaminsky C (2020) In: Haematologica, Online ahead of print. Forschungsartikel (Zeitschrift)